ANGO vs TMO · rev $292.5M vs P/E 24, rev $44.56B
AngioDynamics Inc (ANGO) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
ANGO currently screens at market cap $378.5M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the ANGO and TMO stock pages for the full models.
Not investment advice.